Cargando…

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma

Treatment options and risk stratification for esophageal adenocarcinomas (EAC) currently rely on pathological criteria such as tumor staging. However, with advancement in immune modulated treatments, there is a need for accurate predictive biomarkers that will help identify high-risk patients and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babar, Laila, Kosovec, Juliann E., Jahangiri, Vida, Chowdhury, Nobel, Zheng, Ping, Omstead, Ashten N., Salvitti, Madison S., Smith, Matthew A., Goel, Ajay, Kelly, Ronan J., Jobe, Blair A., Zaidi, Ali H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642049/ https://www.ncbi.nlm.nih.gov/pubmed/31360303 http://dx.doi.org/10.18632/oncotarget.27052

Ejemplares similares

Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model
por: Zaidi, Ali H., et al.
Publicado: (2021)

Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma
por: Matsui, Daisuke, et al.
Publicado: (2016)

CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease
por: Kosovec, Juliann E., et al.
Publicado: (2017)

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
por: Matani, Hirsch, et al.
Publicado: (2022)

Magnetic Sphincter Augmentation and Postoperative Dysphagia: Characterization, Clinical Risk Factors, and Management
por: Ayazi, Shahin, et al.
Publicado: (2019)

High yield reproducible rat model recapitulating human Barrett’s carcinogenesis
por: Matsui, Daisuke, et al.
Publicado: (2017)

The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy
por: Kosovec, Juliann E., et al.
Publicado: (2018)

Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence
por: Ayazi, Shahin, et al.
Publicado: (2019)

Prognostic Value and Targeted Inhibition of Survivin Expression in Esophageal Adenocarcinoma and Cancer-Adjacent Squamous Epithelium
por: Malhotra, Usha, et al.
Publicado: (2013)

Establishing Magnetic Resonance Imaging as an Accurate and Reliable Tool to Diagnose and Monitor Esophageal Cancer in a Rat Model
por: Kosovec, Juliann E., et al.
Publicado: (2014)

Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma
por: Zaidi, Ali H., et al.
Publicado: (2016)

Comparison of surgical payer costs and implication on the healthcare expenses between laparoscopic magnetic sphincter augmentation (MSA) and laparoscopic Nissen fundoplication (LNF) in a large healthcare system
por: Ayazi, Shahin, et al.
Publicado: (2019)

MicroRNA Signature Characterizes Primary Tumors That Metastasize in an Esophageal Adenocarcinoma Rat Model
por: Zaidi, Ali H., et al.
Publicado: (2015)

Measurement of outflow resistance imposed by magnetic sphincter augmentation: defining normal values and clinical implication
por: Ayazi, Shahin, et al.
Publicado: (2020)

Tumor Microenvironment before and after Chemoradiation in Locally Advanced Rectal Cancer: Beyond PD-L1
por: Tayshetye, Pritam, et al.
Publicado: (2022)

The Utility of Symptom Association Probability (SAP) in Predicting Outcome After Laparoscopic Fundoplication in Patients with Abnormal Esophageal Acid Exposure
por: Vaiciunaite, Donata, et al.
Publicado: (2023)

Esophageal Lichen Planus: Understanding a Potentially Severe Stricturing Disease
por: Rao, Bharat, et al.
Publicado: (2017)

Esophageal adenocarcinoma with metastatic skin nodules and Budd–Chiari syndrome
por: Singh, S, et al.
Publicado: (2021)

Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma
por: Nobel, Tamar, et al.
Publicado: (2019)

Chemoprevention of esophageal adenocarcinoma
por: Snider, Erik J, et al.
Publicado: (2020)

ASO Author Reflections: Predicting Early Recurrence After Trimodality Therapy for Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Serum miR-331-3p predicts tumor recurrence in esophageal adenocarcinoma
por: Gu, Jianchun, et al.
Publicado: (2018)

Recurrent esophageal adenocarcinoma derived from ectopic gastric mucosa: A case report
por: Kitasaki, Nao, et al.
Publicado: (2022)

Esophageal retention cyst: Esophagogastric junction outflow obstruction (EGJOO) as a potential etiology and management with endoscopic mucosal resection (EMR)
por: Mehta, Nisarg, et al.
Publicado: (2022)

Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
por: Dulak, Austin M., et al.
Publicado: (2013)

Port site recurrence of esophageal adenocarcinoma after minimally invasive esophagectomy: a case report
por: Horino, Taichi, et al.
Publicado: (2020)

A Case of Pembrolizumab-Induced Diabetic Ketoacidosis and Hyperthyroidism in a Patient With Recurrent Esophageal Adenocarcinoma
por: Salangsang, Jonathan, et al.
Publicado: (2023)

Esophageal Adenocarcinoma Originating from the Esophageal Gland Duct
por: Kono, Mitsuhiro, et al.
Publicado: (2018)

Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma
por: Lv, Jing, et al.
Publicado: (2019)

Vitiligo Associated with Esophageal Adenocarcinoma
por: Asilian, Ali, et al.
Publicado: (2013)

Esophageal adenocarcinoma: Methods and protocols
por: Samarasam, Inian
Publicado: (2019)

Epidemiology of early esophageal adenocarcinoma
por: Hang, Thuy-Van P., et al.
Publicado: (2022)

Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma
por: Mourikis, Thanos P., et al.
Publicado: (2019)

A case of recurrent stroke with underlying adenocarcinoma: Pseudo-cryptogenic stroke
por: Goel, Deepak, et al.
Publicado: (2020)

Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Band Ligation Resolves Esophageal Adenocarcinoma Overlying Esophageal Varix
por: Hadley, Steven M., et al.
Publicado: (2022)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Emerging therapeutic targets in esophageal adenocarcinoma
por: Gaur, Puja, et al.
Publicado: (2016)

The Role of Microbiota in the Pathogenesis of Esophageal Adenocarcinoma
por: Gillespie, Megan R., et al.
Publicado: (2021)

Genomic and Transcriptomic Characteristics of Esophageal Adenocarcinoma
por: Hoppe, Sascha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h82dd3fficok4mteef1ltjdb1d